Objectives -Suspected cerebrospinal fluid shunt (CSF) dysfunction in hydrocephalic patients poses a diagnostic uncertainty. The clinical picture can be non-specific and CT imaging alone is not always pathognomonic. Infusion tests are an increasingly used investigation for real-time hydrodynamic assessment of shunt patency. We report the correlation between infusion test results with the quality of ventricular drain placement on CT scans in a large retrospective group of hydrocephalic patients. Materials & methods -Three hundred and six infusion test results performed in 200 patients were correlated with 306 corresponding CT head scans. Nominal logistic regression was used to correlate shunt catheter position on CT imaging to patency of ventricular drain as determined by infusion tests. Results -Infusion test results of shunt patency are statistically congruent with the analysis of shunt catheter position on CT head scans. Catheter tips completely surrounded by either parenchyma or CSF on CT imaging are strongly associated with evidence of occlusion or patency from infusion tests, respectively (v² = 51.68, P < 0.0001, n = 306 and v² = 31.04, P < 0.0001, n = 306). Conclusions -The most important anatomical factor for shunt patency is the catheter tip being completely surrounded by CSF. Infusion tests provide functional and reliable assessment of shunt patency in vivo and are strongly correlated with the position of the ventricular catheter on CT imaging.
Introduction
Only modest progress has been made in preventing ventriculoperitoneal shunt failure for several decades (1) . Shunt revision is still a common neurosurgical operation, posing significant risks to patients and a heavy financial burden on healthcare services (2) . Recent long-term studies have quoted shunt failure rates requiring revision surgery of 23% (3) and 46% (4) over 8 years. Mechanical dysfunction accounts for 74% of such revisions (3) with occlusion of the proximal catheter being the most common site for obstruction (5) .
Electron microscopic and histological evidence from blocked ventricular and peritoneal catheters show that the cause of occlusion is often debris from choroid plexus and ependyma (6, 7) . Therefore, it has been suggested that the optimal position for the tip of the ventricular catheter ought to be in the ipsilateral frontal horn anterior to the foramen of Monro (8) (9) (10) , as the choroid plexus is absent from this part of the ventricle.
As Albright and colleagues quoted only 55% of the frontally placed catheters were in 'good' position in 1988 (11) , with functional shunt survival related to positioning, more recent studies still quote high risk of suboptimally placed frontal catheters, up to 56% (12) . This is in part likely due to the fact that the freehand ventriculostomy has traditionally been undertaken as a 'blind' procedure, relying on surface anatomical landmarks to guide insertion. This notion is supported by studies of other procedures requiring 'blind' ventriculostomy such as external ventricular drain insertion which also show high incidence of suboptimal ventricular catheter positioning (13, 14) . Unsurprisingly, this has led to a shift towards using image guidance or other tools to aid in improving the accuracy of ventricular cannulation (12, 15) .
Many studies investigating shunt dysfunction have used the clinical assessment of patients, the decision to revise a shunt and computed tomography (CT) imaging to assess catheter position and changes in ventricular size as surrogate markers to infer the patency of shunts (1, 3, 4, 7) . Increasingly in clinical practice, infusion tests are being undertaken as a means to objectively measure the flow dynamics of fluid within shunts in vivo (16) (17) (18) (19) , especially when the diagnosis of shunt dysfunction is not clearly evident from the clinical presentation and changes in ventricular size on CT alone, which may never happen in normal pressure hydrocephalus (NPH) . Although infusion test technique may be seen as little bit outdated, and new theories for development of hydrocephalus are proposed (20) , use of infusion test to scrutinize shunt performance in vivo seems to be clinically well funded (21) .
In this study, we investigate the relationship between ventricular catheter position on CT scans using an objective classification and their effect on the patency of a shunt ventricular catheters as assessed by infusion tests. The study was conducted retrospectively using the CT and infusion test investigations performed on patients with symptoms of shunt dysfunction where the diagnosis was ambiguous (i.e. clinical and radiological evidence was insufficient for proceeding with shunt revision surgery and hence referred for infusion tests to aid diagnosis).
Materials and methods
A retrospective, non-controlled, observational cohort was studied. All data used were derived from clinical records of patients at Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust. Due to the use of retrospective historical records and no active patient involvement during the data collection, patient consent for the use of data in research was taken preemptively by Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, as part of routine protocol. Patients who had an infusion test on the basis of clinical symptoms of ventriculoperitoneal shunt dysfunction between 2007 and 2011 were identified. The results of their infusion tests were analysed and classified according to the state of ventricular drain -either obstructed or patent (see descriptions below).
To correlate these physiological evaluations of shunt patency with the anatomical position of the proximal catheter tips, we analysed the CT head scans for the same patients within this period using a new classification system. We excluded scans with a greater than 3-month interval between scan and infusion test, and any patients that had revision operations within this time to ensure that the same shunt proximal catheter was being assessed physiologically by infusion test and radiologically by CT scan. Data from both the physiological and radiological assessments were correlated statistically.
Infusion test and its analysis
The infusion test is a technique, modified from the 'constant-infusion manometric test' described by Katzman and Hussey (22) . It involves the insertion of two 25-G butterfly needles into the subcutaneous shunt reservoir, which is connected with the intraventricular catheter. Via one needle, saline is infused at a constant rate, whilst the other records pressure changes (Fig 1 upper  panel) . During the infusion, the computer calculates and presents mean pressure and pulse amplitude [with time along the X-axis (see Fig. 1 lower  panel) ]. Pressure increases slowly, as a compliance of CSF space is substantial and pulse amplitude of pressure waveform usually increases proportionally to pressure. The resistance to CSF outflow can be calculated using simple arithmetic as the difference between the value of the plateau pressure during infusion and the resting pressure divided by the infusion rate. Repeatability of calculation of the resistance to CSF outflow has been investigated before (23) . However, the precise measurement of the final pressure plateau is not possible when strong vasogenic waves arise or an excessive elevation of the pressure above the safe limit of 40 mm Hg is recorded. Computerized analysis produces results even in difficult cases when the infusion is terminated prematurely. The algorithm utilizes time series analysis for volume-pressure curve retrieval, the leastmean-square model fitting and an examination of the relationship between the pulse amplitude and the mean CSF pressure. The pressure-volume curve is investigated.
Infusion Through the second needle, infusion is performed. Transducer sends electric signal to pressure amplifier and computer, and running infusion-supporting software reads the signal from the output of amplifier (usual sampling frequency is 100 Hz). Lower panel: Typical x-time plot of pressure recorded during study. At the baseline, pressure remains usually stable. When infusion is started (this case: 1.5 ml/min rate -it is indicated by vertical bar), pressure starts to rise gradually to reach after certain time (12 min in this case) plateau level. Resistance to CSF outflow is calculated as plateau pressure minus baseline pressure, divided by infusion rate [in this case (32-10 mm Hg)/1.5 ml/min = 14.6 mm Hg/(ml/min)]. X-axis: time in format: date/hours/mins.
For the purposes of this study, we classified groups 1 and 2 above as shunts with patent ventricular drain and groups 3 and 4 as obstructed.
Each group has a distinct pattern on the pressure waveform produced during the infusion test. In the following two figures, the differences between functional and a proximally obstructed shunt are demonstrated.
In Fig. 2 , three essential features consistent with patent ventricular shunt catheters system are illustrated. Firstly, the normal baseline intracranial pressure (ICP) increases slowly to the value characterizing the resistance to CSF outflow. Secondly, the heart rate is detectable throughout the infusion phase and lastly the pulse amplitude (AMP) is recordable, both features demonstrating patency of the ventricular drain. Both pulse amplitude (AMP) and heart rate (HR) are estimated using adaptive heart rate tracking spectral analysis method. One thousand and twenty-four point discrete power spectrum is calculated using 10-s intervals of sampled (100 Hz) ICP signal. Spectrum peak associated with a heart rate (measured using distal plethysmographic method) is identified manually to start the algorithm. Then, it is tracked from one window to another during the course of the study. AMP is calculated from a power of first harmonic of spectral peak. During this procedure, much of the fluid goes into the brain depending on CSF resistance to outflow possibly against sagittal sinus pressure and further down the shunt after its opening pressure is exceeded. Fig. 3 demonstrates several key differences in an obstruction of ventricular drain of shunt system. There is no pulse waveform of ICP recorded at baseline. Primarily, the ICP immediately rises to the pressure level (shunt opening pressure plus abdominal pressure level) above which the valve opens distally. When the distal flow is obstructed during the test (e.g. by pressing siphon control device), the pressure rises further and without any delay, demonstrating an isolated circuit not in continuation with the ventricular space. The estimated heart rate is erratic and inconsistent and the pulse amplitude remains almost undetectable, which further shows a lack of continuity between the shunt and ventricular space. Opposite to previous scenario ( Fig. 2) , during this procedure all infused fluid presumably goes down the shunt into the abdomen influenced by the valve resistance, opening pressure, length of catheter and abdominal pressure.
For distal obstruction, plateau pressure reached during the study (Fig. 2) exceeds the level evaluated as: valve's opening pressure plus infusion rate times hydrodynamic resistance of the opened valve plus certain credit for abdominal pressure (5 mm Hg in non-obese patients) (21, 25) .
CT analysis
The electronic records of the patients who had undergone the 499 infusion tests between 2007 and 2011 were screened to identify those with a CT head scan within 3 months of the test and no surgery between the test and scan. Although ventricle size can change rapidly, the positioning of ventricular catheters tends to stay static in serial imaging; hence, this large time frame was chosen to allow for greater data capture whilst minimizing bias from different ventricular catheters (26) .
In total, 306 CT head scans of 200 patients were analysed. No coronal or 3D reconstructions Figure 2 . Infusion test showing the waveforms for a functional shunt. ICP, mean ICP; HR, heart rate; AMP, pulse amplitude (first harmonic) of pulsatile waveform. This is a case with patent ventricular inlet. Pressure rises gradually to reach the plateau, pulse amplitude changes proportionally to mean ICP, and heart rate is followed continuously. 'Critical threshold' is a pressure level, calculated for specific type of shunt (Strata, performance level 1), as infusion rate time shunt's hydrodynamic resistance plus opening pressure plus credit for abdominal pressure (5 mm Hg). In this case, plateau pressure did not exceed 'critical threshold', which indicates that the shunt is patent distally.
were used. This was to simplify the analysis and ensure ease of transferability so that other clinicians could assess their scans in the same way. The slice thickness was 5 mm per axial cut.
Some patients had repeated clinical presentations where shunt dysfunction was considered leading to repeat infusion tests and CT scans. In those cases, classification of infusion tests and scans was interpreted as independent.
For this CT analysis, a new classification tool was designed by the investigators to define the anatomical position of the proximal catheter tip. The goal was to create a highly specific, reproducible, easy-to-use and objective measure of location. This was achieved via the creation and use of simple categories with mutually exclusive options, which in combination can exhaustively express all possible tip positions and determines relevant anatomical relationships to aid in the comparison of shunt tip positions. These are outlined below: The classification of tip position relative to surroundings assesses the immediate environment of the drainage holes at the distance of 1.5 cm of the ventricular catheter. The word 'completely' clearly divides those shunts in an optimal position (CSF) from those in a definitively suboptimal position (parenchyma) and groups those in between. This third group refers to those catheter tips which would be lying partially against a ventricular wall, brain parenchyma, septum pellucidum or lying within the foramen of Monro, for example, whilst being partially surrounded by CSF.
For a catheter tip to be classified as anterior to the foramen of Monro, it had to lie within the ventricular space anterior to a coronal plane in line with the foramen. We also made an additional record in the cases where the catheter tip was seen to pass into the foramen of Monro, rather than remaining anterior to it.
A midline classification refers to those shunt tips which lie along midline structures such as septum pellucidum or the third ventricle. A classification of contralateral position means that the tip has passed across the midline structures. 'Collapsed ventricles' refers to the radiographic evidence of narrowed or slit ventricles.
Shunt tip position on CT is a surrogate marker for the actual tip, as the CT axial plane slices are between 5 and 10 mm generating a small margin of error. Additionally, the drainage holes in the catheter are not limited to the tip and extend proximally for between 15 and 30 mm. A general scheme of catheter tip position classification and relevant examples are presented in Fig. 4 .
Reliability
Thirty CT scans from our sample were selected using a random number generator and were then Figure 3 . Infusion test showing the waveforms produced in proximal obstruction. Pressure in shunt prechamber is arbitrary, without pulse waveform (AMP almost zero) and erratic (non-continuous) detection of the heart rate. After start of infusion, pressure rises almost immediately (no delay, means that the compliance of the system is much lower than in Fig. 2 ) to the value above opening level for the shunt plus abdominal pressure. During infusion, if this is possible (it is possible in shunts like a Strata or Delta -with distal membrane siphon control device), distal occlusions are performed. Pressure rises immediately to very high values and decreases immediately after release of the occlusion.
independently re-analysed by each of the first three authors using the classification system described above. These results were statistically compared to assess for interobserver variability and thus assess the overall reliability of our method.
Statistical analysis
Nominal logistical models were used to analyse the effect of the explanatory variables (CT classification descriptors) and their biologically relevant two-way interactions on the dependent variable (shunt patency or proximal occlusion detected during infusion test), and were subject to stepwise removal starting with the least significant interaction term. All rejected terms were individually reintroduced to the reduced model to confirm they did not improve final model performance. Analyses were performed in JMP 7 (SAS Institute, Marlow, UK).
Results
Three hundred and six infusion studies of in vivo shunts and their corresponding CT head scans were analysed. The age range of the patients was 1-88 years with a mean age of 42 and the gender ratio was 2:3 (male: female). The median time between scan and infusion test was 1 day (interquartile range: 0-9 days). Table 1 details the results of the analysed CT head scans as categorized by proximal shunt patency determined by infusion test.
Of 306 tests, 57 showed pattern of proximal blockage. The proximal patency of the shunt on infusion test was significantly associated with the matter it was surrounded by on CT scan (Table 2) .
If the shunt was completely surrounded by brain parenchyma on CT scan, it had the highest likelihood of obtaining an infusion test result consistent with occlusion (33/62 occluded = 53.22%; v² = 51.68, P < 0.0001, n = 306). If the shunt was completely surrounded by CSF, it had the least likelihood of becoming occluded (2/92 occluded = 2.17%, v² = 31.04, P < 0.0001) as shown in Fig. 5 . Shunts that were partially surrounded by both brain and CSF were significantly worse than being surrounded by CSF and significantly better than being surrounded by brain, with a highly significant difference between the two extreme groups (parenchyma versus CSF, P < 0.000001). None of the remaining categories for classifying catheter tip position on CT were significantly associated with proximal patency or proximal blockage detected during infusion test (Table 2) . Of the 249 infusion tests with results of hydrodynamic patency, 29 had their catheter tips surrounded by parenchyma (12%).
Our model provided no evidence for frontal or parietal approach shunts to be significantly different in likelihood of patency, when the effect size from surrounding matter was removed. In addition, for the frontal shunts with catheter tips in the frontal horn of the lateral ventricle, further data were collected to classify the position within the ventricle (anterior to foramen of Monro, through foramen of Monro and abutting septum pellucidum). The location of these catheter tips was also not significantly associated with patency. Intra-observer agreement has been tested additionally and was assessed as high (v 2 = 2.65; P = 0.85).
Although this was not a formal subject of the current study, unconfirmed incidence of distal blockage was 72 cases (23%). Incidence of cases with patent shunt (normal resistance to CSF outflow) but presumably increased abdominal pressure was 25 (8%). In total, almost 50% of infusion tests suggested shunt malfunction and the remainder had no evidence of malfunction on Infusion Test.
Discussion
In approximately 19% of infusion tests in patients with clinical symptoms of problems potentially associated with shunt malfunction, proximal occlusion was seen. Infusion test results of proximal patency were very strongly associated with the position of the ventricular catheter tip on CT head imaging. Patients proven to have proximally blocked shunts by infusion test were highly likely to have their ventricular catheter tips surrounded by brain parenchyma on CT imaging. Conversely, patients in whom infusion tests confirmed a patent shunt were highly likely to have ventricular catheter tips surrounded by CSF on CT head imaging. This study shows such a reliable 'hydrodynamic' patency relationship with radiological positioning using 'in vivo' shunts.
Distal blockage and raised abdominal pressure can be found in 32% of cases. In total, almost a half of symptomatic patients have shunts assessed as 'patent' on infusion test. This may help to avoid the costs and potential clinical complications of unnecessary shunt revision operations with the additional of an infusion test, which is cheap, fast, minimally invasive and low risk.
Furthermore, this study uses a new, simple and reliable classification system to assess the position of ventricular catheter tips on CT head imaging, based on the prior hypotheses of previous works to suggest optimal catheter tip targets (8) (9) (10) (11) . It is the unambiguous nature of this classification system, which has determined the effect of positioning factors on shunt patency. The only factor to significantly affect shunt patency was the type of matter immediately surrounding the catheter tip. A post hoc analysis showed that parietal shunts were more likely than frontal shunts to be blocked on infusion test, but this effect was due to the parietal shunts being less likely to be completely surrounded by CSF. This may be due to the anatomy of the body and trigone of the lateral ventricles in having smaller dimensions than the frontal horns and also containing choroid plexus, which has been implicated in causing shunt blockage. The suggestions for 'optimal' tip location to be anterior to the foramen of Monro in the ipsilateral frontal horn of the lateral ventricle (8-11) are supported by the findings of this study. All catheter tips in this optimal position that were completely surrounded by CSF were found to be patent on infusion test; 40/40 (100%) of optimally positioned catheters were completely surrounded by CSF, but only 52/266 (21%) of suboptimally positioned were completely surrounded by CSF.
Only 57 infusion tests had results of hydrodynamic evidence of blockage, 19% of the whole group. We speculate that without this objective assessment of patency, a larger percentage of the group may have undergone exploratory/revision surgery on the basis of clinical presentation and CT findings.
Also of note, of the 249 infusion tests with results of hydrodynamic patency, 29 had their catheter tips surrounded by parenchyma (12%). It is plausible that these cases may be draining periventricular oedema or extracellular/interstitial fluid hence their 'patency', but in the context of the other results of the study, we suspect such catheters to be of very high risk of future blockage from the solid matter surrounding the catheter tips. Although the most important anatomical factor for shunt patency is the catheter tip being completely surrounded by CSF, it is useful to perform additional infusion tests prior to proceeding to shunt revision surgery in patients with ambiguous clinical presentation. The results of the test (if it is performed correctly) sometimes show 'functional' state of the shunt system, which may differ from 'anatomical' arrangements.
In total, 12% of the patients had a patent catheter with hydrodynamic tests despite catheter tips being surrounded by parenchyma. In our opinion, although it is not included in the subject of the study, those patients are of high risk of future shunt blockage and warrant close clinical observation for signs of this happening.
There is an interesting result in Table 1 that it is much more common with collapsed ventricles in 'blocked shunts' group (31% vs 12%). In such cases, first is probably overdrainage, which causes ventricles to collapse and close the ventricular inlet.
Clinical context
The results of this study support the previous arguments (8-11) of ensuring optimal ventricular catheter tip positioning. We propose that the success of shunt patency in these optimal locations is due to the higher likelihood, anatomically, of the catheter tip being completely surrounded by CSF. Hayhurst et al. (15) demonstrated the efficacy of image guidance in ensuring such optimal positioning and in view of the inherent difficulty in blind insertion of ventricular catheters based on surface anatomical landmarks alone, this work supports such methods to ensure CSF surrounds the catheter tip of a potentially lifelong implanted device. Our results support the suggestion of a recent report by Yamada et al. (27) to consider early revision surgery for catheter tips found to be in poor positions such as intraparenchymal or along a ventricular wall. Our results also support the usage of medium-/high-pressure shunt valves or judiciously lowering the pressure setting on programmable valves in order to avoid rapid collapse of the CSF space causing the ventricular walls to surround the catheter tip instead of CSF.
Our results specifically validate the usage of infusion studies in routine clinical practice as a reliable, low-risk investigation to assess shunt dysfunction. Its usefulness for assessment of shunt patency has been also confirmed by others (18, 19) . Infusion study is a practical tool not only for testing a shunt functioning in vivo (16, 17, 25) but also for evaluation of shunt hydrodynamic performance in laboratory settings (21, 28, 29) . The latter can serve as a comparative pattern for in vivo study.
Our data show a very strong statistical correlation between the results of the infusion test and the radiological catheter position on CT, a routinely used investigation in neurosurgical units for assessing patients with symptoms of shunt dysfunction. Not only do infusion studies provide a 'hydrodynamic' real-time in vivo assessment of shunt patency to aid the clinician in decisionmaking, in cases where other aspects of assessment are compromised, their value is even more marked. Examples include paediatric patients, patients with learning difficulties, specific neurological or psychiatric comorbidities and patients with severe traumatic brain injury where a direct history of symptoms is not feasible or in cases where the ventricles do not alter dimensions on CT imaging in response to raised CSF pressure. Additionally, an infusion test confirming shunt patency can be a useful reassurance from clinicians to patients who may equate headaches to shunt blockages requiring revision surgery.
Limitations
In this study, we compared location of ventricular catheter tip versus results of infusion study dichotomized as ventricular catheter blocked or patent. We did not consider distal blockage (valve itself or distal end) because for these cases imaging classification is not relevant.
We excluded patients with grossly abnormal intracranial anatomy, cranioplasties, decompressive craniectomy defects and multiple shunt catheters. Hence, the conclusions and recommendations of this study cannot be easily generalized to those patient groups. We also excluded patients whose scans and infusion tests were greater than 3 months apart. This was to help ensure that the same catheters were being assessed radiologically and hydrodynamically. Assessment of ventricular size in itself was not undertaken as this patient group was more ambiguous in the diagnosis of shunt dysfunction and there was not always 'baseline' imaging to compare against as many of the patients have been referred after their primary shunt surgery in other centres. This has also meant that data for interval from shunt insertion to infusion test and full aetiological clinical picture at shunt insertion were not always available and hence not included in analysis, which may also be a source of bias.
Additionally, some patients underwent multiple CT scans and infusion studies due to repeated presentations with symptoms of shunt dysfunction, and the data from these cases may also be a source of bias.
We reduced measurement bias by blinding researchers to the shunt status when assessing tip position on imaging and using an objective classification system demonstrated to not have significant interobserver variability.
The design of the study has specifically not incorporated the intraoperative findings of those patients who went on to shunt revision. We realize that this is often the gold standard check of shunt patency; however, due to the limitations inherent with such data, for example lack of standardization between intraoperative findings, missing data and uncontrolled intraoperative factors such as variable carbon dioxide partial pressure concentration affecting intracranial pressure, it was deemed that such analysis would be more confounding. Hence, analysis was restricted to the imaging of catheter position and the hydrodynamic infusion test alone. However, our previous study performed on smaller simple size demonstrated high level of intraoperatively shunt blockage confirmation (90%) (16) .
Aside from the clinical recommendations above, the methods in this study have advantages for being re-applied in future clinical shunt research. A meta-analysis of previous studies relied on the decision for surgical revision of a shunt as the surrogate for shunt dysfunction without confirming in all cases whether intraoperative findings were concordant with the decision (1); this may not be as robust as patency/blockage demonstrated by infusion test which may be a better surrogate in future research. Other classification systems have been used to categorize proximal catheter tip position (10, 11, 15, 27) ; our system has been developed from the anatomical concepts of these previous systems. However, our system is clear, easy to apply, exhaustive in describing all possible catheter tip positions, leaves little room for ambiguity in analysis and has statistical reliability to demonstrate interobserver agreement. Both paradigms for radiological and physiological assessment of shunts in vivo may prove useful for future research.
Conclusion
Infusion tests provide a reliable assessment of proximal shunt patency in vivo as correlated with the position of the ventricular catheter on CT imaging. The most important anatomical factor is the catheter tip being completely surrounded by CSF.
